CANNONE, Valentina

CANNONE, Valentina  

Dipartimento di Medicina e Chirurgia  

Mostra records
Risultati 1 - 20 di 64 (tempo di esecuzione: 0.158 secondi).
Titolo Data di pubblicazione Autore(i) File
Aging and oral health: Effects in hard and soft tissues 1-gen-2010 Guiglia, R.; Musciotto, A.; Compilato, D.; Procaccini, M.; Lo Russo, L.; Ciavarella, D.; Lo Muzio, L.; Cannone, V.; Pepe, I.; D'Angelo, M.; Campisi, G.
Aldosterone in the General Community: Biomarker or Mediator of Cardiorenal and Metabolic Disease 1-gen-2013 Buglioni, Alessia; Cannone, Valentina; Cataliotti, Alessandro; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Sarzani, Riccardo; Burnett, John C.
Aldosterone Level in the General Community Predicts New Onset Cardiometabolic Disease 1-gen-2014 Buglioni, A; Cannone, V; Sangaralingham, Sj; Heublein, Dm; Scott, Cg; Bailey, Kr; Rodeheffer, Rj; Sarzani, R; Burnett, Jc
Aldosterone predicts cardiovascular, renal, and metabolic disease in the general community: A 4-year follow-up 1-gen-2015 Buglioni, Alessia; Cannone, Valentina; Sangaralingham, S. Jeson; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Sarzani, Riccardo; Burnett, John C.
Aldosterone, Cardiorenal and Metabolic Disease in a General Community in Olmsted County, Minnesota: Biomarker and/or Mediator 1-gen-2013 Buglioni, A; Cannone, V; Cataliotti, A; Heublein, Dm; Scott, Cg; Bailey, Kr; Rodeheffer, Rj; Sarzani, R; Burnett, Jc
Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population 1-gen-2018 Cannone, V.; Buglioni, A.; Sangaralingham, S. J.; Scott, C.; Bailey, K. R.; Rodeheffer, R.; Redfield, M. M.; Sarzani, R.; Burnett, J. C.
Aldosterone: Marker and Predictor of Cardiorenal and Metabolic Disease in the General Community 1-gen-2014 Buglioni, Alessia; Cannone, Valentina; Sangaralingham, S. Jeson; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Sarzani, Riccardo; Burnett, John C.
The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure 1-gen-2014 Cannone, Valentina; Barlera, Simona; Pileggi, Silvana; Masson, Serge; Franzosi, Maria Grazia; Latini, Roberto; Scardulla, Cesare; Clemenza, Francesco; Maggioni, Aldo P.; Nicolosi, Gian Luigi; Tavazzi, Luigi; Burnett, John C.
The ANP Genetic Variant rs5068 Is Associated with Higher Circulating Concentrations of Natriuretic Peptides in Patients with Chronic Heart Failure 1-gen-2013 Cannone, Valentina; Barlera, Simona; Pileggi, Silvana; Masson, Serge; Franzosi, Maria Grazia; Latini, Roberto; Scardulla, Cesare; Clemenza, Francesco; Maggioni, Aldo P.; Nicolosi, Gian Luigi; Tavazzi, Luigi; Burnett, John C.
Association of NPPA rs5065 Genetic Variant With Increased Cardiovascular Risk in the General USA Population 1-gen-2010 Cannone, Valentina; Boerrigter, Guido; Costello-Boerrigter, Lisa C.; Cataliotti, Alessandro; Bailey, Kent R.; Lahr, Brian; Heublein, Denise M.; Rodeheffer, Richard J.; Olson, Timothy M.; Burnett, John C.
The atrial natriuretic peptide genetic ariant rs5068 is associated with a favorable cardiometabolic phenotype in a mediterranean population 1-gen-2013 Cannone, Valentina; Cefalu, Angelo Baldassare; Noto, Davide; Scott, Christopher G.; Bailey, Kent R.; Cavera, Giovanni; Pagano, Michele; Sapienza, Michelangelo; Averna, Maurizio R.; Burnett Jr., John C.
An atrial natriuretic peptide genetic variant (rs5065) in the general US population identifies risk for cerebrovascular accidents 1-gen-2010 Cannone, V; Boerrigter, G; Costello-Boerrigter, L; Cataliotti, A; Bailey, Kr; Lahr, B; Heublein, Dm; Rodeheffer, Rj; Olson, Tm; Burnett, JC Jr
Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: A 9-year follow-up study 1-gen-2013 Cannone, Valentina; Huntley, Brenda K.; Olson, Timothy M.; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Redfield, Margaret M.; Rodeheffer, Richard J.; Burnett, John C.
Atrial natriuretic peptide: A molecular target of novel therapeutic approaches to cardio-metabolic disease 1-gen-2019 Cannone, V.; Cabassi, A.; Volpi, R.; Burnett, J. C.
Bisphosphonate-associated femoral fracture: Implications for management 1-gen-2008 Napoli, Nicola; Pepe, Ilenia; Reinaarmamento-Villareal, Null; Agrusa, Antonino; Ritarinella, Maria; Scozzari, Francesca; Florianaadragna, Null; Costanzagaglio, Edy; Cusumano, Gaspare; Martorana, Umberto; Gasparegulotta, Null; Cannone, Valentina
The BNP genetic variant rs198389: cardiovascular phenotype and risk in stage A/B heart failure subjects from the STOP-HF Trial 1-gen-2018 Cannone, V; Watson, C; Ledwidge, M; Burnett, Jc; Mc Donald, K
THE BNP GENETIC VARIANT RS198389: HYPERTENSION RISK AND CARDIOVASCULAR PHENOTYPE IN STAGE A AND STAGE B HEART FAILURE SUBJECTS FROM THE STOP-HF TRIAL 1-gen-2018 Ledwidge, M; Cannone, V; Watson, C; Burnett, J; Mcdonald, K
Can a cardiac peptide predict mortality in human hypertension? 1-gen-2011 Cannone, Valentina; Mckie, Paul M.; Burnett Jr., John C.
A cardio-metabolic phenotype in carriers of NPPA (rs5086) and NPPB (rs198389) gene variants in the general population: the dominant role of ANP 1-gen-2018 Fuglestad, A; Sangaralingham, Sj; Cannone, V; Scott, Cg; Burnett, Jc
A cardiometabolic protective phenotype associated with the ANP genetic variant rs5068 in African Americans: the Multi-Ethnic Study of Atherosclerosis (MESA) 1-gen-2015 Cannone, V; Decker, Pa; Larson, Nb; Scott, Cg; Palmas, W; Taylor, Kd; Bielinski, Sj; Burnett, Jc